Effects of valinomycin, ouabain, and potassium on glycolysis and intracellular pH of Ehrlich ascites tumor cells

Summary

Both valinomycin and ouabain block reaccumulation of K⁺ by Ehrlich ascites tumor cells depleted of K⁺ and cause loss of K⁺ from high-K⁺ cells. Glucose largely reverses the effect of valinomycin and to a lesser extent that of ouabain.

In cells depleted of K⁺, glucose utilization and lactate production are impaired. Neither extracellular pH (pH_e) nor intracellular pH (pH_i) falls to the extent seen in non-depleted glycolyzing cells. Addition of K⁺ to depleted cells reverses these effects. Valinomycin increases glycolysis in K⁺-depleted cells but to a greater extent in nondepleted or K⁺-repleted cells. The increase in lactate production caused by valinomycin is accompanied by a correspondingly greater fall in pH_e and pH_i. Valinomycin, unlike other uncoupling agents, does not abolish the pH gradient across the plasma membrane. Increased utilization of glucose resulting from addition of K⁺ to K⁺-depleted cells or addition of valinomycin either to depleted or non-depleted cells can be entirely accounted for by increased lactate production. Ouabain blocks the stimulatory effect of added K⁺ on K⁺-depleted cells and has an inhibitory effect on glycolysis in non-depleted cells. It does not obliterate the difference in glycolytic activity between K⁺-depleted and nondepleted cells. Ouabain does not completely block the effect of valinomycin in augmenting glycolysis in depleted or non-depleted cells. Increased accumulation of glycolytic intermediates, particularly dihydroxyacetone phosphate, is found in glycolyzing K⁺-depleted cells. The most marked accumulation was found in ouabain-treated K⁺-deficient cells.